Compared with vs DPP4 inhibitors, SGLT2 inhibitors reduce the risk for kidney and ureteral stones in patients with type 2 diabetes, including those with a stone history. Sodium-glucose cotransporter 2 ...
While randomized comparative trials are needed, a relatively new treatment option for upper urinary tract cancers shows ...
Boston Scientific (NYSE:BSX – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a ...
Patients with low-grade upper tract urothelial carcinoma receiving primary treatment with 6 once-weekly pyelocalyceal doses ...
Application of the ACE-Star Evidence-Based Nursing Model Combined with Voice Training in Voice Rehabilitation after Vocal Cord Polyp Surgery ...
After hours: March 13 at 7:59:33 PM EDT Loading Chart for BSX ...
Impact and progress Frontiers' impact Progress Report 2022 All annual reports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback